Literature DB >> 9799070

Regression of massive tumoral calcinosis of the ischium in a dialysis patient after treatment with reduced calcium dialysate and i.v. administration.

T Apostolou1, M Tziamalis, C Christodoulidou, P Fountas, A Billis.   

Abstract

BACKGROUND: Tumoral calcinosis, an inherited metabolic disorder, has been described with increasing frequency over the last 20 years [Drueke 1966]. It is characterized by massive calcium phosphate deposits in periarticular tissues, usually around large joints, especially the hips, knees and elbows (editorial in Lancet 1987). PATIENT AND
METHOD: We describe a 58-year-old male patient with tumoral calcinosis of the ischium and severe hyperparathyroid bone disease, successfully treated with reduced calcium dialysate and vitamin D.
CONCLUSION: We believe that in cases of tumoral calcification with histologically proven hyperparathyroid bone disease, lowering the calcium dialysate concentration together with careful administration of vitamin analogs and monitoring of serum calcium, phosphate and parathyroid hormone levels, may be the ideal therapeutic approach. Control of hyperphosphatemia would be best achieved with measures other than administration of aluminium phosphate binders if one wishes to avoid the induction of adynamic bone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799070

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  1 in total

1.  Osteoclast-like multi-nucleated giant cells in uraemic tumoral calcinosis.

Authors:  Shunsuke Yamada; Masatomo Taniguchi; Masanori Tokumoto; Kazuhiko Tsuruya; Mitsuo Iida
Journal:  NDT Plus       Date:  2009-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.